Sign up to save your podcasts
Or
Share B-Cell Malignancies: Why Not All BTK Inhibitors Are Created Equal
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
B-Cell Malignancies: Why Not All BTK Inhibitors Are Created Equal
Join our expert faculty as they discuss next-generation BTK inhibitors, with a focus on specificity, efficacy, and tolerability.
Credit available for this activity expires: 11/16/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/962783?src=mkm_podcast_addon_962783
View all episodes
By Medscape Podcasts
4
77 ratings
Join our expert faculty as they discuss next-generation BTK inhibitors, with a focus on specificity, efficacy, and tolerability.
Credit available for this activity expires: 11/16/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/962783?src=mkm_podcast_addon_962783
More shows like Keeping Current
View all
Merriam-Webster's Word of the Day
1,263 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
506 Listeners
Neurology® Podcast
298 Listeners
Science Quickly
1,396 Listeners
HBR IdeaCast
145 Listeners
This Week in Cardiology
895 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
299 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
The Peter Attia Drive
7,995 Listeners
Annals On Call Podcast
197 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
373 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
439 Listeners